• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,001.62 498.77
( 0.66%)
Global Indices
Nasdaq
46,970.79 391.31
(0.84%)
Dow Jones
6,721.52 68.33
(1.03%)
Hang Seng
53,528.27 -222.88
(-0.41%)
Nikkei 225
10,338.98 77.83
(0.76%)
Forex
USD-INR
92.32 0.03
(0.03%)
EUR-INR
105.40 -1.04
(-0.98%)
GBP-INR
122.05 -1.31
(-1.06%)
JPY-INR
0.58 0.00
(-0.37%)

EQUITY - MARKET SCREENER

Emmsons International Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532038
INE073C01015
-1950.7804167
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
2.64
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Vivanza Biosciences reports consolidated net loss of Rs 1.00 crore in the March 2025 quarter
May 13,2025
Net Loss of Vivanza Biosciences reported to Rs 1.00 crore in the quarter ended March 2025 as against net loss of Rs 0.41 crore during the previous quarter ended March 2024. Sales declined 89.14% to Rs 0.48 crore in the quarter ended March 2025 as against Rs 4.42 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.67 crore in the year ended March 2025 as against net profit of Rs 0.55 crore during the previous year ended March 2024. Sales declined 73.35% to Rs 7.42 crore in the year ended March 2025 as against Rs 27.84 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.484.42 -89 7.4227.84 -73
OPM %-200.00-2.94 --4.853.84 -
PBDT-0.99-0.26 -281 -0.650.71 PL
PBT-0.99-0.27 -267 -0.670.70 PL
NP-1.00-0.41 -144 -0.670.55 PL